2-[(2-methylphenoxy)methyl]benzoyl cyanide | CAS:143211-11-4

We serve 2-[(2-methylphenoxy)methyl]benzoyl cyanide CAS:143211-11-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-[(2-methylphenoxy)methyl]benzoyl cyanide

CAS No: 143211-11-4
Product Name: 2-[(2-methylphenoxy)methyl]benzoyl cyanide
Other Name:
2-[(2-methylphenoxy)methyl]benzoyl cyanide
 
Density: 1.166 g/cm3
Boiling Point: 399.6ºC at 760 mmHg
Molecular Formula: C16H13NO2
Molecular Weight: 251.28000
Flash Point: 174.8ºC
Exact Mass: 251.09500
PSA: 50.09000
LogP: 3.28028
 
Specification
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Kresoxim-methyl CAS: 143390-89-0.
Be used as pesticide intermediate, mainly used in the synthesis of the fungicide Kresoxim-methyl.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-[(2-methylphenoxy)methyl]benzoyl cyanide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(2-methylphenoxy)methyl]benzoyl cyanide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(2-methylphenoxy)methyl]benzoyl cyanide Use and application,2-[(2-methylphenoxy)methyl]benzoyl cyanide technical grade,usp/ep/jp grade.


Related News: Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.5-Amino-1H-imidazole-4-carboxamide hydrochloride manufacturer Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.D-Arginine supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.TERT-NONYL MERCAPTAN vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.The company has now selected a single engineered iPSC clone, and generated and fully-characterized the master engineered iPSC bank for GMP production of FT819.